Inspire Medical Systems (INSP) Institutional Ownership

94.91% of Inspire Medical Systems' stock is owned by institutional investors. Learn more on INSP's institutional investor holdings.

Of the 360 institutional investors that purchased Inspire Medical Systems' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($2.21M), Dragoneer Investment Group LLC ($1.93M), Fuller & Thaler Asset Management Inc. ($1.35M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($984.38K), M&T Bank Corp ($937.18K), Deerfield Management Company L.P. ($907.69K), and Marshall Wace LLP ($818.58K).

Institutional investors have bought a total of 20,506,900 shares in the last 24 months. This purchase volume represents approximately $1.86B in transactions.

Of the 142 institutional investors that sold Inspire Medical Systems' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wasatch Advisors LP ($1.52M), Invesco Ltd. ($765.79K), Janus Henderson Group PLC ($653.63K), JPMorgan Chase & Co. ($637.12K), Balyasny Asset Management L.P. ($427.13K), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($370.28K), and Congress Asset Management Co. ($360.28K).

Institutional investors have sold a total of 10,278,361 shares in the last 24 months. This volume of shares sold represents approximately $876.85M in transactions.